No records
|
377 |
Dharma S., Dakota I., Firdaus I., Danny S.S., Zamroni D., Yudha A., Susanto A., Siswanto B.B. |
55101301700;55796663700;55796864700;56221848700;57215684617;57223107725;57225841633;14422648800; |
Performance of Primary Angioplasty for STEMI during the COVID-19 Outbreak |
2021 |
International Journal of Angiology |
30 |
2 |
210001 |
148 |
154 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104870014&doi=10.1055%2fs-0041-1727133&partnerID=40&md5=5b349c0b1a14cb4af4bcc5b822d2e435 |
Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jl S Parman Kav 87, Slipi, Jakarta Barat, Jakarta, 11420, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Catheterization Laboratory Nurse Manager, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
Dharma, S., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jl S Parman Kav 87, Slipi, Jakarta Barat, Jakarta, 11420, Indonesia; Dakota, I., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Firdaus, I., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Danny, S.S., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Zamroni, D., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Yudha, A., Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Susanto, A., Catheterization Laboratory Nurse Manager, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Siswanto, B.B., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
There has been concern whether the declining cases of ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) outbreak associate with primary angioplasty performance. We assessed the performance of primary angioplasty in a tertiary care hospital in Jakarta, Indonesia, by comparing the door-to-device (DTD) time and thrombolysis in myocardial infarction (TIMI) flow after angioplasty between two periods of admission: during the outbreak of COVID-19 (March 1 to May 31, 2020) and before the outbreak (March 1, to May 31, 2019). Overall, there was a relative reduction of 44% for STEMI admission during the outbreak (n = 116) compared with before the outbreak (N = 208). Compared with before the outbreak period (n = 141), STEMI patients who admitted during the outbreak and received primary angioplasty (n = 70) had similar median symptom onset-to-angioplasty center admission (360 minutes for each group), similar to radial access uptake (90 vs. 89.4%, p = 0.88) and left anterior descending infarct-related artery (54.3 vs. 58.9%, p = 0.52). The median DTD time and total ischemia time were longer (104 vs. 81 minutes, p < 0.001, and 475.5 vs. 449 minutes, p = 0.43, respectively). However, the final achievement of TIMI 3 flow was similar (87.1 vs. 87.2%), and so was the in-hospital mortality (5.7 vs. 7.8%). During the COVID-19 outbreak, we found a longer DTD time for primary angioplasty, but the achievement of final TIMI 3 flow and in-hospital mortality were similar as compared with before the outbreak. Thus, primary angioplasty should remain the standard of care for STEMI during the COVID-19 outbreak. © 2020. International College of Angiology. All rights reserved. |
COVID-19 outbreak; performance measures; primary angioplasty |
acetylsalicylic acid; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; clopidogrel; creatinine; dipeptidyl carboxypeptidase inhibitor; heparin; salicylic acid; simvastatin; ticagrelor; adult; angioplasty; Article; cardiovascular risk factor; catheterization; controlled study; coronary angiography; coronavirus disease 2019; creatinine blood level; door to device time; emergency ward; epidemic; female; fibrinolytic therapy; health care utilization; heart left bundle branch block; hospital admission; hospital discharge; human; in-hospital mortality; Indonesia; information processing; ischemia time; length of stay; major clinical study; male; non ST segment elevation myocardial infarction; observational study; outcome assessment; percutaneous coronary intervention; pos |
Thieme Medical Publishers, Inc. |
10611711 |
|
|
Article |
Q3 |
293 |
15070 |
|
|
378 |
Mori Y., Sato H., Kumazawa T., Mayang Permata T.B., Yoshimoto Y., Murata K., Noda S.-E., Kaminuma T., Ando K., Oike T., Okonogi N., Okada K., Kakoti S., Suzuki K., Ikota H., Yokoo H., Nakano T., Ohno T., Shibata A. |
57210846989;55697961900;57210432294;57197808751;36453407100;36103294900;14621772700;23994005700;55641963900;36453136000;36453127400;57222984111;57197814645;57376271900;57214213081;55588986400;35353843800;35395665700;8323572900; |
Analysis of radiotherapy-induced alteration of CD8+ T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma |
2021 |
Oncology Letters |
21 |
6 |
446 |
|
|
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104336493&doi=10.3892%2fol.2021.12707&partnerID=40&md5=a047e0e92118f6cb0de5b48cfc613e96 |
Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Department of Radiotherapy, Saitama Cancer Center, Ina, Saitama, 362-0806, Japan; Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta, 10430, Indonesia; Department of Radiation Oncology, Fukushima Medical University, Fukushima, 960-1247, Japan; Department of Radiation Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Saitama, 350-1298, Japan; National Institute of Radiological Sciences, National Institute for Quantum and Radiological Science and Technology, Chiba, 263-8555, Japan; Signal Transduction Program, Gunma University Initiative for Advanced Research, Gunma University, Maebashi, Gunma, 371-8511, Japan; Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, 852-8523, Japan; Clinical Department of Pathology, Gunma University Hospital, Maebashi, Gunma, 371-8511, Japan; Department of Human Pathology, Gunma University, Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan |
Mori, Y., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan, Department of Radiotherapy, Saitama Cancer Center, Ina, Saitama, 362-0806, Japan; Sato, H., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Kumazawa, T., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Mayang Permata, T.B., Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta, 10430, Indonesia; Yoshimoto, Y., Department of Radiation Oncology, Fukushima Medical University, Fukushima, 960-1247, Japan; Murata, K., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Noda, S.-E., Department of Radiation Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Saitama, 350-1298, Japan; Kaminuma, T., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Ando, K., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Oike, T., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Okonogi, N., National Institute of Radiological Sciences, National Institute for Quantum and Radiological Science and Technology, Chiba, 263-8555, Japan; Okada, K., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Kakoti, S., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan, Signal Transduction Program, Gunma University Initiative for Advanced Research, Gunma University, Maebashi, Gunma, 371-8511, Japan; Suzuki, K., Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, 852-8523, Japan; Ikota, H., Clinical Department of Pathology, Gunma University Hospital, Maebashi, Gunma, 371-8511, Japan; Yokoo, H., Department of Human Pathology, Gunma University, Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan; Nakano, T., National Institute of Radiological Sciences, National Institute for Quantum and Radiological Science and Technology, Chiba, 263-8555, Japan; Ohno, T., Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma, 371-8511, Japan; Shibata, A., Signal Transduction Program, Gunma University Initiative for Advanced Research, Gunma University, Maebashi, Gunma, 371-8511, Japan |
Radiotherapy induces an immune response in the cancer microenvironment that may influence clinical outcome. The present study aimed to analyse the alteration of CD8+ T-cell infiltration and programmed death-ligand 1 (PD-L1) expression following radiotherapy in clinical samples from patients with uterine cervical squamous cell carcinoma. Additionally, the current study sought to analyse the associa- tion between these immune responses and clinical outcomes. A total of 75 patients who received either definitive chemoradio- therapy or radiotherapy were retrospectively analyzed. CD8+ T-cell infiltration and PD-L1 expression were determined by immunohistochemistry using biopsy specimens before radio- therapy (pre-RT) and after 10 Gy radiotherapy (post-10 Gy). The PD-L1+ rate was significantly increased from 5% (4/75) pre-RT to 52% (39/75) post-10 Gy (P<0.01). Despite this increase in the PD-L1+ rate post-10 Gy, there was no significant association between both pre-RT and post-10 Gy and overall survival (OS), locoregional control (LC) and progression-free survival (PFS). On the other hand, the CD8+ T-cell infiltration density was significantly decreased for all patients (median, 23.1% pre-RT vs. 16.9% post-10 Gy; P=0.038); however, this tended to increase in patients treated with radiotherapy alone (median, 17.7% pre-RT vs. 24.0% post-10 Gy; P=0.400). Notably, patients with high CD8+ T-cell infiltration either pre-RT or post-10 Gy exhibited positive associations with OS, LC and PFS. Thus, the present analysis suggested that CD8+ T-cell infiltration may be a prognostic biomarker for patients with cervical cancer receiving radiotherapy. Furthermore, immune checkpoint inhibitors may be effective in patients who have received radiotherapy, since radiotherapy upregu- lated PD-L1 expression in cervical cancer specimens. © 2021 Spandidos Publications. All rights reserved. |
CD8+ T cell; Cervical cancer; Immune modulation; Programmed death-ligand 1; Radiotherapy; Tumor microenvironment |
alcohol; biological marker; biotin; cisplatin; citric acid; diaminobenzidine; edetic acid; formaldehyde; hydrogen peroxide; immune checkpoint inhibitor; paraffin; peroxidase; platinum; programmed death 1 ligand 1; streptavidin; adult; aged; antigen retrieval; Article; biopsy; brachytherapy; cancer radiotherapy; cancer staging; CD8+ T lymphocyte; cell density; cell infiltration; chemoradiotherapy; controlled study; diagnostic test accuracy study; down regulation; female; follow up; human; human tissue; immune response; immunohistochemistry; irradiation; lymph node metastasis; major clinical study; microscopy; overall survival; paraffin embedding; progression free survival; protein expression; receiver operating characteristic; retrospective study; room temperature; tumor associated leukocyt |
Spandidos Publications |
17921074 |
|
|
Article |
Q3 |
766 |
6367 |
|
|
379 |
Pranata R., Lim M.A., Huang I., Yonas E., Henrina J., Vania R., Lukito A.A., Nasution S.A., Alwi I., Siswanto B.B. |
57201973901;57216039756;57208576645;57201987097;57218482646;57208328436;57213835420;57189373134;15055173800;14422648800; |
Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis |
2021 |
Clinical Nutrition ESPEN |
43 |
|
|
163 |
168 |
|
9 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104309308&doi=10.1016%2fj.clnesp.2021.04.001&partnerID=40&md5=e8122f7c8b69f82d927a6b4a78d83d7a |
Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Balaraja General Hospital, Tangerang, Indonesia; Division of Plastic, Reconstructive and Aesthetic, Department of Surgery, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, Indonesia; Department of Cardiology and Vascular Medicine, Siloam Hospitals Lippo Village, Tangerang, Indonesia; Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/ Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
Pranata, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Lim, M.A., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Huang, I., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Yonas, E., Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Henrina, J., Balaraja General Hospital, Tangerang, Indonesia; Vania, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Division of Plastic, Reconstructive and Aesthetic, Department of Surgery, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, Indonesia; Lukito, A.A., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Department of Cardiology and Vascular Medicine, Siloam Hospitals Lippo Village, Tangerang, Indonesia; Nasution, S.A., Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/ Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Alwi, I., Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/ Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Siswanto, B.B., Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
Background and aims: Body mass index (BMI) has previously been shown to increase mortality and disease severity in patients with COVID-19, but the pooled effect estimate was heterogeneous. Although BMI is widely used as an indicator, it cannot distinguish visceral from subcutaneous fat. This systematic review and meta-analysis aimed to investigate the association between visceral adiposity, subcutaneous fat, and severe COVID-19. Methods: We performed a systematic literature search using the databases: PubMed, Embase, and EuropePMC. Data on visceral fat area (VTA), subcutaneous fat area (SFA), and total fat area (TFA) were collected. The outcome of interest was severe COVID-19. We used a REML random-effects model to pool the mean differences and odds ratio (OR). Results: There were 5 studies comprising of 539 patients. Patients with severe COVID-19 have a higher VTA (mean difference 41.7 cm2 [27.0, 56.4], p < 0.001; I2: 0%) and TFA (mean difference 64.6 cm2 [26.2, 103.1], p = 0.001; I2: 0%). There was no significant difference in terms of SFA between patients with severe and non-severe COVID-19 (mean difference 9.3 cm2 [-4.9, 23.4], p = 0.199; I2: 1.2%). Pooled ORs showed that VTA was associated with severe COVID-19 (OR 1.9 [1.1, 2.2], p = 0.002; I2: 49.3%). Conclusion: Visceral adiposity was associated with increased COVID-19 severity, while subcutaneous adiposity was not. Prospero id: CRD42020215876. © 2021 European Society for Clinical Nutrition and Metabolism |
Adiposity; Coronavirus; Obesity; Visceral fat; Visceral fat area |
Article; artificial ventilation; body composition; body mass; cardiovascular disease; coronavirus disease 2019; critical illness; diabetes mellitus; disease exacerbation; disease severity; human; hypertension; intensive care unit; intra-abdominal fat; meta analysis; mortality; Newcastle-Ottawa scale; nonhuman; obesity; observational study; respiratory tract intubation; Severe acute respiratory syndrome coronavirus 2; shock; subcutaneous fat; systematic review; abdominal obesity; aged; body mass; comorbidity; complication; female; intra-abdominal fat; male; metabolism; middle aged; severity of illness index; subcutaneous fat; Adiposity; Aged; Body Mass Index; Comorbidity; COVID-19; Female; Humans; Intra-Abdominal Fat; Male; Middle Aged; Obesity; Obesity, Abdominal; SARS-CoV-2; Severity of I |
Elsevier Ltd |
24054577 |
|
34024509 |
Article |
Q2 |
659 |
7601 |
|
|
380 |
Kurniawan R., Nur R.J.B., Yuliyanti S., Nuridzin D.Z., Kartinah N.T. |
57189681782;57222637045;57222633264;57222637716;57192914846; |
Healthy family index assessment through community-based health information system approach |
2021 |
International Journal of Public Health Science |
10 |
2 |
|
394 |
400 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103597839&doi=10.11591%2fijphs.v10i2.20751&partnerID=40&md5=fe1ac4f92382153c62ee102a2fadb48f |
Department of Biostatistic and Population Study, Faculty of Public Health, Universitas Indonesia, Indonesia; Research Center for Biostatistics and Health Informatics, Faculty of Public Health, Universitas Indonesia, Indonesia; Department of Physiology Pre-Clinic, Faculty of Medicine, Universitas Indonesia, Indonesia |
Kurniawan, R., Department of Biostatistic and Population Study, Faculty of Public Health, Universitas Indonesia, Indonesia; Nur, R.J.B., Research Center for Biostatistics and Health Informatics, Faculty of Public Health, Universitas Indonesia, Indonesia; Yuliyanti, S., Research Center for Biostatistics and Health Informatics, Faculty of Public Health, Universitas Indonesia, Indonesia; Nuridzin, D.Z., Research Center for Biostatistics and Health Informatics, Faculty of Public Health, Universitas Indonesia, Indonesia; Kartinah, N.T., Department of Physiology Pre-Clinic, Faculty of Medicine, Universitas Indonesia, Indonesia |
The healthy Indonesia program with a family approach (PIS-PK) has not been implemented optimally. There are several obstacles and challenges in this program’s implementation, e.g., human resources. A community-based health information system (CBHIS) is a strategic approach to obtain data and information at the population level by directly involving cadres and the community. A project with the CBHIS approach was implemented in Kasemen Village, Serang, Banten Province, Indonesia to support the PIS-PK program. The study aimed to determine the population’s health status according to the healthy family index through the CBHIS approach. The data of healthy family indicators in the village were collected by cadres using a mHealth application. Overall, 1316 households consisting of 5312 residents were registered. The analysis results of the healthy family index showed that most families in the Kasemen subdistrict were pre-healthy (64.2%), almost one third were unhealthy (27.8%) and only a small proportion were healthy (8%). Assessing the healthy family index through the CBHIS approach can support decision-making at the community level, thereby determining the magnitude of family health problems and providing appropriate interventions to improve community health status. Well-trained cadres equipped with better electronic data collection tools may be an alternative to community-based data collection. © 2021, Institute of Advanced Engineering and Science. All rights reserved. |
Community-based; Family approach; Health information system; Healthy family index |
|
Institute of Advanced Engineering and Science |
22528806 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
381 |
Chikih C., Suryokusumo G., Sulistomo A. |
57222637163;57205444996;57024018500; |
Effect of acute submaximal physical exercise before decompression dive on tumor necrosis factor alpha concentration among male trained divers |
2021 |
International Journal of Public Health Science |
10 |
2 |
|
289 |
297 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103567616&doi=10.11591%2fijphs.v10i2.20666&partnerID=40&md5=8c8626032d01ce9797442118fb643071 |
Postgraduate Program Occupational Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia; Klinik Hijau Putih 29, Primary Health Care Provider, Indonesia |
Chikih, C., Postgraduate Program Occupational Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia, Klinik Hijau Putih 29, Primary Health Care Provider, Indonesia; Suryokusumo, G., Postgraduate Program Occupational Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia; Sulistomo, A., Postgraduate Program Occupational Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia |
The increase of inflammatory biomarkers due to decompression dive is one of the factors that could cause decompression sickness (DCS), one of them is tumor necrosis alpha (TNFα). According to the preconditioning theory, exercise before dive can reduce amount of gas bubble to prevent DCS. This study aimed to prove that exercise before diving can prevent increase of TNFα. This study employed quasi-experimental design with trained male divers. The subject divided into two groups, treatment and control. The treatment group got submaximal exercise with 70% heart rate intensity, using cycle ergometer with young men's Christian association (YMCA) procedure modify by Guritno, 24 hours before decompression dive 280 kPa bottom time 80 minute with US-NAVY table, whereas the control group only do decompression dive. TNFα expression was checked three times, at beginning of study, before dive and after dive. In treatment group there was insignificant decrease TNFα, from 7.06±1.85pg./ml to 6.75±1.81pg./ml, whereas the control group showed a significant increased TNFα, from 8.22 (1.45 to 13.11)pg./ml to 8.39 (1.73 to 12.18)pg/ml, and significant difference was found between the mean difference for two groups p<0.05. It can be concluded that acute submaximal exercise prevents an increase of TNFα after single dive decompression to prevent possibility occurring DCS). © 2021, Institute of Advanced Engineering and Science. All rights reserved. |
Decompression dive; Physical exercise; Preconditioning; Prevention of DCS; TNFα |
|
Institute of Advanced Engineering and Science |
22528806 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
383 |
Pranata R., Henrina J., Yonas E., Putra I.C.S., Cahyadi I., Lim M.A., Munawar D.A., Munawar M. |
57201973901;57218482646;57201987097;57222144236;57221688594;57216039756;56470745000;16747447600; |
BMI and atrial fibrillation recurrence post catheter ablation: A dose-response meta-analysis |
2021 |
European Journal of Clinical Investigation |
51 |
6 |
e13499 |
|
|
|
3 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101961208&doi=10.1111%2feci.13499&partnerID=40&md5=72dba8a2a9279126fd9e453324e6df70 |
Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Binawaluya Cardiac Center, Jakarta, Indonesia; Balaraja General Hospital, Tangerang, Indonesia; Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Syamsudin SH General Hospital, Sukabumi, Indonesia; Pasar Rebo General Hospital, Jakarta, Indonesia; Department of Cardiology, Lyell McEwin Hospital, University of Adelaide, Elizabeth Vale, Australia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Pranata, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Binawaluya Cardiac Center, Jakarta, Indonesia; Henrina, J., Balaraja General Hospital, Tangerang, Indonesia; Yonas, E., Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Putra, I.C.S., Syamsudin SH General Hospital, Sukabumi, Indonesia; Cahyadi, I., Pasar Rebo General Hospital, Jakarta, Indonesia; Lim, M.A., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Munawar, D.A., Department of Cardiology, Lyell McEwin Hospital, University of Adelaide, Elizabeth Vale, Australia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Munawar, M., Binawaluya Cardiac Center, Jakarta, Indonesia, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Introduction: The evidence on the association between obesity and atrial fibrillation (AF) recurrence was equivocal. We aimed to evaluate the dose-response relationship between body mass index (BMI) and AF recurrence and adverse events. Methods: A systematic literature search was conducted using PubMed, Europe PMC, EBSCO, ProQuest and Cochrane Library. Obesity was defined as BMI ≥28 kg/m2. The primary outcome was AF recurrence, and the secondary outcome was adverse events. Adverse events were defined as procedure-related complications and cardio-cerebrovascular events. Results: There were a total of 52,771 patients from 20 studies. Obesity was associated with higher AF recurrence (Odds ratio [OR] 1.30 [95% confidence interval [CI] 1.16-1.47], P <.001; I2: 72.7%) and similar rate of adverse events (OR 1.21 [95% CI 0.87-1.67], P =.264; I2: 23.9%). Meta-regression showed that the association varies by age (coefficient: −0.03, P =.024). Meta-analysis of highest versus lowest BMI showed that the highest group had higher AF recurrence (OR 1.37 [95% CI 1.18-1.58], P <.001; I2: 64.9%) and adverse events (OR 2.02 [95% CI 1.08-3.76], P =.028; I2: 49.5%). The linear association analysis for AF recurrence was not significant (P =.544). The dose-response relationship for BMI and AF recurrence was nonlinear (pnonlinearity < 0.001), the curve became steeper at 30-35 kg/m2. For adverse events, an increase of 1% for every 1 kg/m2 increase in BMI (OR 1.01 [95% CI 1.00-1.02], P =.001), the relationship was nonlinear (pnonlinearity = 0.001). Conclusion: Obesity was associated with higher AF recurrence in patients undergoing catheter ablation. High BMI might be associated with a higher risk for adverse events. PROSPERO ID: CRD42020198787. © 2021 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd |
arrhythmia; Atrial Fibrillation; catheter ablation; obesity; pulmonary vein isolation |
anticoagulant agent; warfarin; adult; adverse event; age; aged; Article; atrial fibrillation; body mass; cardiovascular disease; catheter ablation; cerebrovascular disease; female; high risk patient; human; male; meta analysis; middle aged; obesity; outcome assessment; recurrence risk; systematic review; atrial fibrillation; body mass; obesity; recurrent disease; severity of illness index; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Humans; Obesity; Overweight; Recurrence; Severity of Illness Index |
John Wiley and Sons Inc |
00142972 |
|
33544873 |
Article |
Q1 |
1164 |
3461 |
|
|
384 |
Octaviana F., Yugo H.P., Safri A.Y., Indrawati L.A., Wiratman W., Ayuningtyas T., Hakim M. |
26029958700;57222124227;57091699300;57205117182;57191920526;57222133312;57216861859; |
Case series: COVID-19 in patients with mild to moderate myasthenia gravis in a National Referral Hospital in Indonesia |
2021 |
eNeurologicalSci |
23 |
|
100332 |
|
|
|
3 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101576141&doi=10.1016%2fj.ensci.2021.100332&partnerID=40&md5=ccc7fd67857e6642deba6a14cfa9ae62 |
Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia; Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia |
Octaviana, F., Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia, Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia; Yugo, H.P., Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia, Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia; Safri, A.Y., Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia, Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia; Indrawati, L.A., Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia, Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia; Wiratman, W., Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia, Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia; Ayuningtyas, T., Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia, Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia; Hakim, M., Neurology Department, Faculty of Medicine, Universitas Indonesia, Indonesia, Cipto Mangunkusomo National General Hospital, Jakarta, Indonesia |
Background: During the COVID-19 pandemic, patients with myasthenia gravis (MG) are most likely to be affected by this situation. Corticosteroids and immunosuppressant agents increase the risk of severe infection. Furthermore, viral infection and some medications in COVID-19 may exacerbate MG symptoms. Case description: We presented three patients with MG who contracted COVID-19. All of the patients had a favourable outcome. Only one patient who was not treated with corticosteroids or immunosuppressant therapy experienced deterioration of MG symptoms, while the other patients who received immunosuppressant therapy did not develop MG exacerbation. Surprisingly, azithromycin did not provoke myasthenic crisis (MC) in patients with normal MGFA classification. Conclusion: Using immunosuppressant agents may not lead to MG deterioration and may not be related to unfavourable outcomes. © 2021 The Author(s) |
COVID-19; Immunosuppressant; Myasthenia gravis |
acetylcysteine; alanine aminotransferase; ascorbic acid; aspartate aminotransferase; azathioprine; azithromycin; C reactive protein; ceftriaxone; D dimer; hydroxychloroquine; methylprednisolone; mycophenolate mofetil; oxygen; paracetamol; procalcitonin; pyridostigmine; abduction; adult; anosmia; Article; blood analysis; body temperature; case report; clinical article; clinical classification; consultation; coronavirus disease 2019; coughing; deterioration; diarrhea; disease exacerbation; drug dose increase; dry cough; dysphagia; fatigue; female; fever; food intake; home quarantine; hospital admission; hospital discharge; hospitalization; human; human tissue; Indonesia; leukocytosis; lung auscultation; lung infiltrate; male; mastication; medical history; middle aged; mucus; muscle weakness; |
Elsevier B.V. |
24056502 |
|
|
Article |
Q3 |
570 |
8868 |
|
|
385 |
Silalahi T., Alwi I., Suyatna F., Sartika K.D. |
56275255400;15055173800;57303311300;57221849323; |
Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease |
2021 |
International Journal of Angiology |
30 |
2 |
200063 |
132 |
138 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100412387&doi=10.1055%2fs-0040-1720969&partnerID=40&md5=d55e2b0c365eafd1a179c7602474794d |
Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia; Division Cardiovascular, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Department of Clinical Pharmacology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Silalahi, T., Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia; Alwi, I., Division Cardiovascular, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Suyatna, F., Department of Clinical Pharmacology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Sartika, K.D., Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia |
Cardiovascular diseases play major roles in the health problems worldwide especially in Indonesia. Percutaneous coronary intervention (PCI) is a minimally invasive procedure with relatively low complications. However, high inflammatory response post-PCI has showed adverse events even after administration of standard medication. Previous studies showed that curcumin was able to reduce inflammatory response in adult patients with stable coronary heart disease (CHD). This article determines the efficacy of oral administration of curcumin in reducing inflammatory response post-PCI with stable CHD. A double-blind randomized controlled trial on 50 adult patients comparing curcumin and placebo was performed in Cipto Mangunkusumo General Hospital and Jakarta Heart Center within April and June 2015. Either curcumin (45 mg/day) or placebo was given 7 days prior to PCI until 2 days after PCI. Inflammatory markers (high-sensitivity C-reactive protein [hsCRP] and soluble CD40 ligand [sCD40L]) were measured in three phases (7 days prior PCI, 24 hours post-PCI, and 48 hours post-PCI). There were no significant differences in the reduction of hsCRP and sCD40L between curcumin and placebo groups in three phases of measurement. Curcumin significantly reduce the serum hsCRP (p = 0.006) and sCD40L (p = 0.002) 7 days before PCI to 48 hours post-PCI. The decrement of hsCRP (-14.2% vs. -7.4%) and sCD40L (-24.3% vs. -13.2%) from 24 to 48 hours post-PCI was higher in the curcumin group than placebo group. The administration of curcumin 45 mg dose daily for 7 days prior PCI until 48 hours post-PCI is useful in reducing inflammatory response post-PCI with stable CHD. © 2020. International College of Angiology. All rights reserved. |
curcumin; inflammatory response; PCI; stable CHD |
acetylsalicylic acid; C reactive protein; CD40 ligand; clopidogrel; curcumin; placebo; adult; Article; clinical article; controlled study; dose response; double blind procedure; drug efficacy; female; human; human tissue; inflammatory disease; ischemic heart disease; male; measurement; middle aged; percutaneous coronary intervention; priority journal; protein blood level; randomized controlled trial; treatment response |
Thieme Medical Publishers, Inc. |
10611711 |
|
|
Article |
Q3 |
293 |
15070 |
|
|
386 |
Oike T., Uchihara Y., Permata T.B.M., Gondhowiardjo S., Ohno T., Shibata A. |
36453136000;57221723636;57197808751;6508327402;35395665700;8323572900; |
Quantitative volumetric analysis of the Golgi apparatus following X-ray irradiation by super-resolution 3D-SIM microscopy |
2021 |
Medical Molecular Morphology |
54 |
2 |
|
166 |
172 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099941107&doi=10.1007%2fs00795-020-00277-z&partnerID=40&md5=67d2ba3ce4cc88d92e3e071747ee2f42 |
Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan; Gunma University Heavy Ion Medical Center, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan; Signal Transduction Program, Gunma University Initiative for Advanced Research (GIAR), 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan; Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital, Jl. P. Diponegoro No. 71, Jakarta, 10430, Indonesia |
Oike, T., Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan, Gunma University Heavy Ion Medical Center, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan; Uchihara, Y., Signal Transduction Program, Gunma University Initiative for Advanced Research (GIAR), 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan; Permata, T.B.M., Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital, Jl. P. Diponegoro No. 71, Jakarta, 10430, Indonesia; Gondhowiardjo, S., Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital, Jl. P. Diponegoro No. 71, Jakarta, 10430, Indonesia; Ohno, T., Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan, Gunma University Heavy Ion Medical Center, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan; Shibata, A., Signal Transduction Program, Gunma University Initiative for Advanced Research (GIAR), 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan |
To obtain quantitative volumetric data for the Golgi apparatus after ionizing radiation (IR) using super-resolution three-dimensional structured illumination (3D-SIM) microscopy. Normal human retinal pigment epithelial (RPE) cells were irradiated with X-rays (10 Gy), followed by immunofluorescence staining of the Golgi marker RCAS1. 3D-SIM imaging was performed using DeltaVision OMX version 4 and SoftWoRx 6.1. Polygon rendering and spot signal identification were performed using Imaris 8.1.2. Differences between groups were assessed by Welch’s t test. RCAS1 signals in untreated cells were located adjacent to nuclei and showed a reticular morphology. Upon IR, the area of RCAS1 signals expanded while retaining the reticular morphology. Polygon rendering imaging revealed that the volume of RCAS1 at 48 h post-IR was greater than that for unirradiated cells (93.7 ± 19.0 μm3 vs. 33.0 ± 4.2 μm3, respectively; P < 0.001): a 2.8-fold increase. Spot signal imaging showed that the number of RCAS1 spot signals post-IR was greater than that for unirradiated cells [3.4 ± 0.8 (× 103) versus 1.3 ± 0.2 (× 103), respectively; P < 0.001]: a 2.7-fold increase. This is the first study to report quantitative volumetric data of the Golgi apparatus in response to IR using super-resolution 3D-SIM microscopy. © 2021, The Author(s). |
3D-SIM; Golgi; Ionizing radiation; RCAS1; Super-resolution microscopy |
article; controlled study; Golgi complex; human; human experiment; immunofluorescence; ionizing radiation; microscopy; quantitative analysis; retina pigment cell; signal transduction; vision; X irradiation; X ray; cell culture technique; epithelium cell; fluorescence microscopy; Golgi complex; procedures; radiation response; retina; three-dimensional imaging; ultrastructure; X ray; Cell Culture Techniques; Epithelial Cells; Golgi Apparatus; Humans; Imaging, Three-Dimensional; Microscopy, Fluorescence; Retina; X-Rays |
Springer Japan |
18601480 |
|
33501611 |
Article |
Q2 |
650 |
7736 |
|
|
387 |
Reksodiputro M.H., Hutauruk S.M., Widodo D.W., Fardizza F., Mutia D. |
35090488800;57205105620;56644646600;55091031700;57221630137; |
Platelet-Rich Fibrin Enhances Surgical Wound Healing in Total Laryngectomy |
2021 |
Facial Plastic Surgery |
37 |
3 |
|
325 |
332 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099660024&doi=10.1055%2fs-0040-1717083&partnerID=40&md5=43744ae74dd367876ae8b58289232fb6 |
Division of Facial Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Division of Larynx Pharynx, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia |
Reksodiputro, M.H., Division of Facial Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Hutauruk, S.M., Division of Larynx Pharynx, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Widodo, D.W., Division of Facial Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Fardizza, F., Division of Larynx Pharynx, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Mutia, D., Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia |
Autologous growth factor (AGF) is a cytokine that has gained medical research interest because it helps improve and accelerate the wound healing process. Platelet-rich fibrin (PRF) is the latest generation of platelet concentrate that can be obtained through a simple procedure known as AGF referencing. One of the most common complications of total laryngectomy (TL) is pharyngocutaneous fistula. To prevent this complication, health care providers must closely monitor the postoperative wound healing process.This study aimed to investigate the effectiveness of PRF application in enhancing wound healing after TL. A randomized controlled trial was conducted in the Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital Universitas Indonesia, Jakarta, Indonesia, from June 2019 to December 2019. We included 20 patients who underwent TL for laryngeal squamous cell carcinoma. They were divided into two groups (10 patients who received applied autologous PRF around the esophageal stoma during TL and another 10 patients as the control). These patients were observed for 2 weeks postoperatively. In the bivariate analysis performed using the chi-square test, the pain threshold and edema of postoperative wounds in the PRF-treated group demonstrated significant differences compared with those in the control group. PRF application in TL enhanced the postoperative wound healing process, especially with regard to edema and pain. © 2021 Thieme Medical Publishers, Inc.. All rights reserved. |
pharyngocutaneous fistula; platelet-rich fibrin; PRF; total laryngectomy |
platelet-rich fibrin; controlled study; human; laryngectomy; randomized controlled trial; surgical wound; wound healing; Humans; Laryngectomy; Platelet-Rich Fibrin; Surgical Wound; Wound Healing |
Thieme Medical Publishers, Inc. |
07366825 |
|
33445196 |
Article |
Q3 |
435 |
11329 |
|
|